ArticleHeliyon2023

S100A9 promotes glycolytic activity in HER2-positive breast cancer to induce immunosuppression in the tumour microenvironment.

Jia-Qi Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.